Chronic hydroxychloroquine therapy and COVID-19 outcomes: A retrospective case-control analysis.
作者信息
Rangel Lauren K, Shah Payal, Lo Sicco Kristen, Caplan Avrom S, Femia Alisa
机构信息
Ronald O. Perelman Department of Dermatology, New York University Grossman School of Medicine, New York, New York.
Ronald O. Perelman Department of Dermatology, New York University Grossman School of Medicine, New York, New York.
出版信息
J Am Acad Dermatol. 2021 Jun;84(6):1769-1772. doi: 10.1016/j.jaad.2020.10.098. Epub 2021 Jan 10.
Abstract
摘要
相似文献
1
Chronic hydroxychloroquine therapy and COVID-19 outcomes: A retrospective case-control analysis.慢性羟氯喹治疗与COVID-19结局：一项回顾性病例对照分析。
J Am Acad Dermatol. 2021 Jun;84(6):1769-1772. doi: 10.1016/j.jaad.2020.10.098. Epub 2021 Jan 10.
2
Hydroxychloroquine efficacy and safety in preventing SARS-CoV-2 infection and COVID-19 disease severity during pregnancy (COVID-Preg): a structured summary of a study protocol for a randomised placebo controlled trial.羟氯喹预防 SARS-CoV-2 感染和妊娠期 COVID-19 疾病严重程度的疗效和安全性（COVID-Preg）：一项随机安慰剂对照试验研究方案的结构化总结。
Trials. 2020 Jul 2;21(1):607. doi: 10.1186/s13063-020-04557-y.
3
Early experimental COVID-19 therapies: associations with length of hospital stay, mortality and related costs.早期 COVID-19 治疗试验：与住院时间、死亡率和相关费用的关系。
Swiss Med Wkly. 2020 Dec 31;150:w20446. doi: 10.4414/smw.2020.20446. eCollection 2020 Dec 14.
4
High doses of hydroxychloroquine do not affect viral clearance in patients with SARS-CoV-2 infection.高剂量羟氯喹对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）感染患者的病毒清除无影响。
Eur J Clin Invest. 2020 Oct;50(10):e13358. doi: 10.1111/eci.13358. Epub 2020 Aug 11.
5
Hydroxychloroquine or Chloroquine for Treatment or Prophylaxis of COVID-19: A Living Systematic Review.羟氯喹或氯喹治疗或预防 COVID-19：一项实时系统评价。
Ann Intern Med. 2020 Aug 18;173(4):287-296. doi: 10.7326/M20-2496. Epub 2020 May 27.
6
Summary for Patients: Postexposure Hydroxychloroquine Prophylaxis to Prevent SARS-CoV-2 Infection.患者摘要：暴露后使用羟氯喹预防新冠病毒感染
Ann Intern Med. 2021 Mar;174(3):I16. doi: 10.7326/P20-0015. Epub 2020 Dec 8.
7
Triple therapy with hydroxychloroquine, azithromycin, and ciclesonide for COVID-19 pneumonia.羟氯喹、阿奇霉素和环索奈德三联疗法治疗 COVID-19 肺炎。
J Microbiol Immunol Infect. 2021 Feb;54(1):109-112. doi: 10.1016/j.jmii.2020.09.003. Epub 2020 Oct 5.
8
Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults exposed to coronavirus disease (COVID-19): a structured summary of a study protocol for a randomised controlled trial.羟氯喹用于接触新冠病毒疾病（COVID-19）后成年人暴露者预防严重急性呼吸综合征冠状病毒 2（SARS-CoV-2）感染的暴露后预防效果：一项随机对照试验研究方案的结构化总结。
Trials. 2020 Jun 3;21(1):475. doi: 10.1186/s13063-020-04446-4.
9
Proactive Prophylaxis With Azithromycin and HydroxyChloroquine in Hospitalised Patients With COVID-19 (ProPAC-COVID): A structured summary of a study protocol for a randomised controlled trial.阿奇霉素和羟氯喹对新冠肺炎住院患者的前瞻性预防（ProPAC-COVID）：一项随机对照试验研究方案的结构化总结
Trials. 2020 Jun 10;21(1):513. doi: 10.1186/s13063-020-04409-9.
Zotero 插件